Abstract
The absolute risk of endometrioid carcinoma of the ovary is very small. When endometriosis is left behind at the time of hysterectomy, there may be increased risk and difficulties in hormone replacement management.
MeSH terms
-
Antineoplastic Agents, Hormonal / adverse effects
-
Carcinoma, Endometrioid / etiology*
-
Endometriosis / complications*
-
Estrogen Replacement Therapy / adverse effects
-
Female
-
Humans
-
Infertility / etiology
-
Ovarian Cysts / therapy
-
Ovarian Neoplasms / etiology*
-
Risk Factors
-
Tamoxifen / adverse effects
Substances
-
Antineoplastic Agents, Hormonal
-
Tamoxifen